Vitruvian Partners’s Hinge Health HNGE Stock Holding History
Bought
Maintained
Sold
Other funds holding HNGE
Vitruvian Partners's HNGE Position: Q3 2026 in Review
Vitruvian Partners reduced its Hinge Health (HNGE) stake by 11% in Q3 2026, selling an estimated $4.96M and leaving 450,000 shares worth $43.8M. The position accounts for 38.62% of the portfolio, ranked #1.
Vitruvian Partners first reported a position in HNGE in Q2 2025 and has held it in 6 quarters since. The position peaked at $64.7M in Q2 2025. 368 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.
- Vitruvian Partners held 450,000 shares of Hinge Health worth $43.8M as of Q3 2026.
- Vitruvian Partners sold 56,599 Hinge Health shares in Q3 2026, an estimated $4.96M.
- Hinge Health made up 38.62% of Vitruvian Partners's portfolio in Q3 2026, its #1 holding.
- Vitruvian Partners first reported a position in Hinge Health in Q2 2025 and has held it in 6 quarters since.
- Vitruvian Partners's Hinge Health position peaked at $64.7M in Q2 2025.
- 368 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.
Based on Vitruvian Partners's 13F filing for Q3 2026, filed 13 Nov 2026.